155 related articles for article (PubMed ID: 14762632)
1. Evaluation of an in-house specific immunoglobulin G (IgG) avidity ELISA for distinguishing recent primary from long-term human cytomegalovirus (HCMV) infection.
de Souza S; Bonon SH; Costa SC; Rossi CL
Rev Inst Med Trop Sao Paulo; 2003; 45(6):323-6. PubMed ID: 14762632
[TBL] [Abstract][Full Text] [Related]
2. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
Prince HE; Leber AL
Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays.
Revello MG; Genini E; Gorini G; Klersy C; Piralla A; Gerna G
J Clin Virol; 2010 Aug; 48(4):255-9. PubMed ID: 20561816
[TBL] [Abstract][Full Text] [Related]
4. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
5. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection.
Gutiérrez J; Piédrola G; Maroto MC
J Infect Dis; 1998 Aug; 178(2):599-600. PubMed ID: 9697755
[No Abstract] [Full Text] [Related]
6. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation.
Vauloup-Fellous C; Berth M; Heskia F; Dugua JM; Grangeot-Keros L
J Clin Virol; 2013 Feb; 56(2):118-23. PubMed ID: 23182774
[TBL] [Abstract][Full Text] [Related]
9. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity.
Baccard-Longere M; Freymuth F; Cointe D; Seigneurin JM; Grangeot-Keros L
Clin Diagn Lab Immunol; 2001 Mar; 8(2):429-31. PubMed ID: 11238233
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
Lagrou K; Bodeus M; Van Ranst M; Goubau P
J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
[TBL] [Abstract][Full Text] [Related]
11. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity.
Blackburn NK; Besselaar TG; Schoub BD; O'Connell KF
J Med Virol; 1991 Jan; 33(1):6-9. PubMed ID: 1849983
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection.
Bodéus M; Goubau P
J Clin Virol; 1999 Jan; 12(1):3-8. PubMed ID: 10073408
[TBL] [Abstract][Full Text] [Related]
14. The role of IgG avidity in diagnosis of cytomegalovirus infection in newborns and infants.
Vilibić-Cavlek T; Ljubin-Sternak S; Vojnović G; Sviben M; Mlinarić-Galinović G
Coll Antropol; 2012 Mar; 36(1):297-300. PubMed ID: 22816235
[TBL] [Abstract][Full Text] [Related]
15. Comparison of IgG avidity assays in the confirmation of the diagnosis of cytomegalovirus primary infection.
Guisasola ME; Ramos B; Sanz JC; García-Bermejo I; De Ory Manchón F
APMIS; 2010 Dec; 118(12):991-3. PubMed ID: 21091781
[TBL] [Abstract][Full Text] [Related]
16. Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy.
Zelini P; Fornara C; Furione M; Sarasini A; Klemens J; Arossa A; Spinillo A; Gerna G; Lilleri D
J Clin Virol; 2019 Nov; 120():38-43. PubMed ID: 31546089
[TBL] [Abstract][Full Text] [Related]
17. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
Weber B; Fall EM; Berger A; Doerr HW
J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
[TBL] [Abstract][Full Text] [Related]
18. Combination of line immunoassays Mikrogen recomLine CMV IgG and recomLine CMV IgG Avidity helps to date the onset of CMV primary infection.
Delforge ML; Eykmans J; Steensels D; Costa E; Donner C; Montesinos I
Diagn Microbiol Infect Dis; 2019 Mar; 93(3):208-212. PubMed ID: 30361044
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection.
Weber B; Berger A; Rabenau H
J Virol Methods; 2001 Aug; 96(2):157-70. PubMed ID: 11445146
[TBL] [Abstract][Full Text] [Related]
20. Application of commercial cytomegalovirus IgG avidity diagnostic kit.
Yang JM; Li JX; Guo ZX
Clin Lab; 2014; 60(8):1377-82. PubMed ID: 25185425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
